Development and evaluation of intranasal liposomal formulation of Memantine for Alzheimer’s disease

Ítems similars

• Formulation and Evaluation of Liposomal Temozolomide for Intranasal Delivery in Glioblastoma Multiforme
  per: Jain Ashish
• Development of Intranasal Liposomes for Nose to Brain Delivery in Parkinson’s Disease
  per: Shah Pankti
• Development and Evaluation of Intranasal Formulation of Galantamine Hydrobromide for Alzhemier's Disease
  per: Yukta Kamat
• Formulation and Evaluation of Baicalein Oral pellets for Alzheimer’s Disease
  per: Agarawal Kopal
• Development and Evaluation of Berberine Nanoformulation for Alzheimer's Disease
  per: Marina Philip Raju